Inseego Brings Flexible Multi-WAN Resilience to Wireless Broadband Offerings 
Indonesia Urges Greater Transparency in Cross-Border Copyright Royalty Governance Before 35 Countries Senti Bio to Present at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
SOUTH SAN FRANCISCO, Calif., April 18, 2022 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (“Senti Bio”),…
Castellum, Inc. Closes on the Acquisition of Lexington Solutions Group
Castellum, Inc. Closes on the Acquisition of Lexington Solutions Group Castellum, Inc. (OTC: ONOV) announces…
Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing Facility
500,000+ square foot facility to support commercial-scale biomanufacturing Livestreaming ceremony with Governor Laura Kelly Live from…
Entasis Therapeutics Presents SUL-DUR Topline Data from Phase 3 ATTACK Trial at ECCMID 2022 Conference
WALTHAM, Mass., April 18, 2022 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a…
AmoyDx Enters into Master Collaboration Agreement with AstraZeneca for Multiple Companion Diagnostics Programs in China, EU and Japan
SHANGHAI, China, April 18, 2022 (GLOBE NEWSWIRE) — Amoy Diagnostics Co., Ltd (AmoyDx), a China…
Taysha Gene Therapies to Participate in Upcoming Chardan Genetic Medicines and Cell Therapy Manufacturing Summit
Chief Executive Officer, Chief Technical Officer, Chief Medical Officer and Head of Research and Development…
Aadi Bioscience to Participate at the Jefferies “Biotech on the Bay” Summit
LOS ANGELES, April 18, 2022 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadi”) (NASDAQ: AADI), a…
Kinnate Biopharma Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of its FGFR Inhibitor Product Candidate, KIN-3248
SAN FRANCISCO and SAN DIEGO, April 18, 2022 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq:…
Fuisz Pharma LLC Announces Patent Issuance for its Non-Invasive Urological Device to Mitigate the Symptoms of Benign Prostate Hyperplasia (BPH)
Williamson County, TN, April 18, 2022 (GLOBE NEWSWIRE) — Fuisz Pharma LLC, an affiliate of…
Aquestive Therapeutics to Report First Quarter 2022 Financial Results and Recent Business Highlights on May 3 and Host Conference Call on May 4 at 8:00 a.m. ET
WARREN, N.J., April 18, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
ContraFect Announces Multiple Presentations of New Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Address Antimicrobial Resistance at the 32nd Annual ECCMID Meeting
YONKERS, N.Y., April 18, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage…
Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of North America
• Ocugen responsible for commercialization of COVAXIN™ in Mexico • COVAXIN™, already authorized for emergency use…
Black Diamond Therapeutics Announces First Patient Dosed in Phase 1 Study of BDTX-1535, a MasterKey Inhibitor of EGFR for the Treatment of Glioblastoma and Non-Small Cell Lung Cancer
– Clinical update expected in second half of 2023 – CAMBRIDGE, Mass. and NEW YORK, April…
Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ex-US Royalty-Based Financing with R-Bridge Healthcare Fund
CHESTERBROOK, Pa., April 18, 2022 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company…
Beyond Air® to Participate in Three Upcoming Medical Conferences
GARDEN CITY, N.Y., April 18, 2022 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a…
TELA Bio Appoints D. Taylor Ocasio as General Counsel
MALVERN, Pa., April 18, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass., April 18, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…
ONCOTELIC PROVIDES YE 2021 FINANCIAL RESULTS COMPARED TO YE 2020, PRODUCT DEVELOPMET INITIATIVES AND CORPORATE UPDATE
AGOURA HILLS, Calif., April 18, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic”, “We” or…
Progress Moves Headquarters, Embracing a Future of Work Centered on Employee Choice
After 30+ years, company sells Bedford, MA campus, moves to Burlington, MA BURLINGTON, Mass., April…
WonderFi Continues Consolidation of Licensed Crypto Platforms Through Accretive Acquisition of Coinberry
Toronto, Ontario–(Newsfile Corp. – April 18, 2022) – WonderFi Technologies Inc. (NEO: WNDR) (OTC Pink: WONDF) (WKN:…